Hubei Guangji Pharmaceutical Co., Ltd. (SHE:000952)
China
· Delayed Price · Currency is CNY 7.27
-0.11 (-1.49%)
Apr 29, 2026, 3:04 PM CST
SHE:000952 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Net Income | -434.32 | -438.95 | -295.29 | -140.25 | 50.33 | 110.11 | Upgrade
|
| Depreciation & Amortization | 160.29 | 160.29 | 165.14 | 119.95 | 98.31 | 91.26 | Upgrade
|
| Other Amortization | 1.79 | 1.79 | 1.92 | 0.77 | 0.01 | 0.12 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.55 | -0.55 | 2.4 | -0.25 | 4.31 | -0.54 | Upgrade
|
| Asset Writedown & Restructuring Costs | 290.32 | 290.32 | 30.68 | 0.12 | 12.28 | 1.15 | Upgrade
|
| Loss (Gain) From Sale of Investments | -18.38 | -18.38 | 27.92 | 9.24 | -6.3 | -18.72 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | -2.8 | 0.14 | - | - | Upgrade
|
| Other Operating Activities | 89.62 | 60.89 | 47.8 | 46.89 | 14.12 | 13.91 | Upgrade
|
| Change in Accounts Receivable | -118.47 | -118.47 | 156.17 | -53.06 | -102.06 | -66.93 | Upgrade
|
| Change in Inventory | 47.79 | 47.79 | -14.16 | -100.18 | -64.33 | -4.35 | Upgrade
|
| Change in Accounts Payable | 90.63 | 90.63 | -114.2 | -44.87 | 29.87 | -47.38 | Upgrade
|
| Change in Other Net Operating Assets | -10.75 | -10.75 | 0.12 | 0.91 | 10.83 | - | Upgrade
|
| Operating Cash Flow | 93.79 | 60.43 | 0.66 | -148.96 | 45.08 | 75.91 | Upgrade
|
| Operating Cash Flow Growth | 94.12% | 9120.66% | - | - | -40.61% | -36.42% | Upgrade
|
| Capital Expenditures | -30.81 | -35.64 | -154.93 | -566.13 | -203.71 | -96.61 | Upgrade
|
| Sale of Property, Plant & Equipment | 6 | 5 | 2.16 | 0.35 | 0 | 0.74 | Upgrade
|
| Divestitures | 10.65 | 55.44 | - | - | - | - | Upgrade
|
| Investment in Securities | - | - | - | - | 80 | -20 | Upgrade
|
| Other Investing Activities | - | - | - | - | 1.97 | 1.76 | Upgrade
|
| Investing Cash Flow | -14.16 | 24.79 | -152.78 | -565.78 | -121.74 | -114.1 | Upgrade
|
| Short-Term Debt Issued | - | - | - | 20 | - | - | Upgrade
|
| Long-Term Debt Issued | - | 742.68 | 766.31 | 1,221 | 739.45 | 388.65 | Upgrade
|
| Total Debt Issued | 768.04 | 742.68 | 766.31 | 1,241 | 739.45 | 388.65 | Upgrade
|
| Long-Term Debt Repaid | - | -794.82 | -660.49 | -559.51 | -438.48 | -399.77 | Upgrade
|
| Total Debt Repaid | -881.62 | -794.82 | -660.49 | -559.51 | -438.48 | -399.77 | Upgrade
|
| Net Debt Issued (Repaid) | -113.58 | -52.13 | 105.82 | 681.09 | 300.97 | -11.12 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 36.19 | - | Upgrade
|
| Repurchase of Common Stock | - | - | -14.51 | -0.44 | - | - | Upgrade
|
| Common Dividends Paid | -49.78 | -50.95 | -50.46 | -31.56 | -40.24 | -35.65 | Upgrade
|
| Other Financing Activities | -22.69 | -22.35 | 2 | 52 | 4.02 | - | Upgrade
|
| Financing Cash Flow | -186.05 | -125.43 | 42.84 | 701.09 | 300.94 | -46.77 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.44 | 0.78 | 1.21 | 0.12 | 1.43 | -1.5 | Upgrade
|
| Net Cash Flow | -106.85 | -39.42 | -108.07 | -13.54 | 225.71 | -86.47 | Upgrade
|
| Free Cash Flow | 62.98 | 24.79 | -154.28 | -715.1 | -158.63 | -20.7 | Upgrade
|
| Free Cash Flow Margin | 9.86% | 3.97% | -24.15% | -96.92% | -19.89% | -2.63% | Upgrade
|
| Free Cash Flow Per Share | 0.18 | 0.07 | -0.44 | -2.02 | -0.45 | -0.06 | Upgrade
|
| Cash Income Tax Paid | 11.96 | 11.62 | -33.62 | 20.53 | 8.91 | 37.53 | Upgrade
|
| Levered Free Cash Flow | -180.03 | -47 | -72.68 | -515.16 | -137.81 | -64.25 | Upgrade
|
| Unlevered Free Cash Flow | -180.03 | -47 | -33.95 | -484.44 | -124.63 | -53.81 | Upgrade
|
| Change in Working Capital | 5.02 | 5.02 | 22.88 | -185.58 | -127.98 | -121.37 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.